Table 1.
Demographic and clinical characteristics of patients with sarcoidosis.
| Variables | Mean | Standard Deviation | No. (%) |
|---|---|---|---|
| Age (years) | 46.9 | 12.5 | |
| Gender | |||
| Males | 37 (35.6) | ||
| Females | 67 (64.4) | ||
| Male: Female ratio | 1: 1.8 | ||
| Smoker | 16 (15.4) | ||
| Non-smoker | 88 (84.6) | ||
| Presenting symptoms | |||
| Dyspnea | 79 (76.0) | ||
| Cough | 75 (72.1) | ||
| Weight loss | 34 (32.7) | ||
| Co-morbid illnesses | |||
| Diabetes mellitus | 33 (31.7) | ||
| Hypertension | 26 (25.0) | ||
| Ischemic heart disease | 7 (6.7) | ||
| Chest radiographic stage | |||
| Stage 0 | 6 (5.8) | ||
| Stage I | 24 (23.1) | ||
| Stage II | 44 (42.3) | ||
| Stage III | 17 (16.3) | ||
| Stage IV | 13 (12.5) | ||
| Extra-pulmonary organ involvement | |||
| Eye | 10 (9.6) | ||
| Liver, spleen | 9 (8.6) | ||
| Skin | 4 (3.8) | ||
| Bone | 3 (2.9) | ||
| Kidneys | 2 (1.9) | ||
| Hypercalcemia | 8 (7.9) | ||
| Other* | 3 (2.9) | ||
| Treatment | |||
| None | 32 (30.8) | ||
| Corticosteroids | 54 (52) | ||
| Corticosteroids + Azathioprine | 8 (7.7) | ||
| Corticosteroids + Methotrexate | 7 (6.7) | ||
| Oxygen therapy | 3 (2.9) | ||
*
Central nervous system, n=1; heart, n=1; muscle, n=1